Rapid and Dramatic Radiographic and Clinical Response to an ALK Inhibitor (Crizotinib, PF02341066) in an ALK Translocation-Positive Patient with Non-small Cell Lung Cancer
- 1 December 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 5 (12), 2044-2046
- https://doi.org/10.1097/jto.0b013e318200f9ff
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor TreatmentClinical Cancer Research, 2010
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- The biology and treatment of EML4-ALK non-small cell lung cancerEuropean Journal Of Cancer, 2010
- ALK Gene Rearrangements: A New Therapeutic Target in a Molecularly Defined Subset of Non-small Cell Lung CancerJournal of Thoracic Oncology, 2009
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALKJournal of Clinical Oncology, 2009
- The Lessons of GIST—PET and PET/CT: A New Paradigm for ImagingThe Oncologist, 2008